Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Members & Subscribers
    • Benefits for CMA Members
    • CPD Credits for Members
    • Subscribe to CMAJ Print
    • Subscription Prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Members & Subscribers
    • Benefits for CMA Members
    • CPD Credits for Members
    • Subscribe to CMAJ Print
    • Subscription Prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
Letters

Evidence-based tobacco-control legislation on e-cigarettes is urgently needed

Nilanga Aki Bandara, Senara Wanniarachchi and Vahid Mehrnoush
CMAJ January 20, 2020 192 (3) E74; DOI: https://doi.org/10.1503/cmaj.73819
Nilanga Aki Bandara
Founding chair, The Global Coalition for Adolescents’ Unique Tobacco Addictions Related Issues; research assistant, Departments of Emergency Medicine and Trauma Surgery, University of British Columbia, Vancouver, BC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Senara Wanniarachchi
Research assistant, University of British Columbia, Vancouver, BC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vahid Mehrnoush
Postdoctoral research fellow, Section of Trauma, Acute Care, and Global Surgery, Vancouver General Hospital, University of British Columbia, Vancouver, BC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Responses
  • Metrics
  • PDF
Loading

According to the US Centers for Disease Control and Prevention, every day about 1600 adolescents under the age of 18 years experiment with their first cigarette, and an additional 200 go on to become daily smokers.1 In fact, more than 95% of adults who are or were daily smokers tried their first cigarette before age 21.1 Therefore, empowering adolescents to avoid unhealthy behaviours is paramount, as we believe it is an important social and public health responsibility.

In a debate on vaping regulations in 2018, some Canadian policy-makers argued that there should be more leeway to advertise the benefits of vaping (e-cigarette) products.2 However, before more leeway is given to advertise the harm-reduction benefits of vaping products, we believe that the first step would be to establish whether vaping products are indeed safe smoking-cessation devices or harm-reduction tools.

How safe is vaping for Canadian adolescents? There is considerable methodologically strong research showing the consequences when adolescents start using these products. A Canadian longitudinal research study showed that among initial nonsmokers, those who use vaping products are more likely to start smoking combustible cigarettes a year later and are more likely to become daily smokers.3 This study was designed to control for susceptibility to cigarette smoking. It should be noted that the prevalence of high school students vapourizing cannabis through e-cigarettes is comparatively higher in Canada4 than in the United States.5

A US study showed that experimenting with e-cigarettes is reversing the previous long-term decline in adolescent smoking.6

In 2017, the Canadian Medical Association (CMA) forwarded its evidence-based recommendations regarding vaping for consideration in the House of Commons.7 The CMA reported that there was very low to low evidence at the time to support vaping as a smoking-cessation device or harm-reduction tool, and further emphasized that the restrictions on promotion of vaping products and devices should be the same as those for tobacco products.7 The conclusions of the CMA are supported by systematic reviews funded by the Canadian Institutes of Health Research8 and the World Health Organization.9

The National Academies of Sciences, Engineering and Medicine (NASEM) in the United States conducted a congressionally mandated comprehensive review of more than 800 peer-reviewed scientific studies on health effects of vaping on adolescents.10 It concluded that “there is substantial evidence that e-cigarette (vaping) use increases risk of ever using combustible tobacco cigarettes among youth and young adults” and “there is moderate evidence for increased cough and wheeze in adolescents who use e-cigarettes and an association with e-cigarette use and an increase in asthma exacerbations.”10

So far there have been more than 50 deaths and more than 2400 injuries related to vaping.11 The harms that e-cigarettes currently pose to nonsmoking teens and young adults far outweigh the potential benefits.12 Therefore, the recommendations of the CMA7 and the NASEM10 should be implemented to protect our vulnerable children and prevent a future tobacco epidemic in Canada.

It is well known that the industry promotes e-cigarettes using youth-friendly social media platforms. The Advertising Standards Authority (ASA), which regulates advertising in the United Kingdom across all media, recently implemented a socially responsible and commendable initiative banning Instagram e-cigarette posts.13 Four vaping companies, including British American Tobacco, have had Instagram posts promoting e-cigarettes banned by the ASA. Meanwhile, the British Broadcasting Corporation emphasized that urgent policy changes are needed from Facebook, Instagram and Twitter. We need to stop advertising harmful and highly addictive tobacco products to young people around the world.

Footnotes

  • Competing interests: None declared

References

  1. ↵
    Youth and tobacco use fact sheets. Atlanta: Centers for Disease Control and Prevention; 2016. Available: www.cdc.gov/tobacco/data_statistics/fact_sheets/youth_data (accessed 2019 Oct. 5).
  2. ↵
    1. Vogel L
    . Parliament debates junk food ads, vaping. CMAJ 2018;190:E406–7.
    OpenUrlFREE Full Text
  3. ↵
    1. Hammond D,
    2. Reid JL,
    3. Cole AG,
    4. et al
    . Electronic cigarette use and smoking initiation among youth: a longitudinal cohort study. CMAJ 2017; 189: E1328–36.
    OpenUrlAbstract/FREE Full Text
  4. ↵
    1. Mammen G,
    2. Jürgen R,
    3. Sergio R
    . Vaporizing cannabis through e-cigarettes: prevalence and sociodemographic correlates among Ontario high school students. Can J Public Health 2016; 107:e337–8.
    OpenUrlPubMed
  5. ↵
    1. Morean ME,
    2. Kong G,
    3. Camenga DR,
    4. et al
    . High school students’ use of electronic cigarettes to vaporize cannabis. Pediatrics 2015;136:611–6.
    OpenUrlAbstract/FREE Full Text
  6. ↵
    1. Barrington-Trimis JL,
    2. Urman R,
    3. Leventhal AM,
    4. et al
    . E-cigarettes, cigarettes, and the prevalence of adolescent tobacco use. Pediatrics 2016;138: e20153983.
    OpenUrlAbstract/FREE Full Text
  7. ↵
    CMA submission: CMA’s recommendations for Bill S-5: An Act to amend the Tobacco Act and the Nonsmokers’ Health Act and to make consequential amendments to other Acts. Ottawa: Canadian Medical Association; 2017. Available: https://legacy.cma.ca//Assets/assets-library/document/en/advocacy/submissions/soci-committee-submission-bill-s-5-en.pdf (accessed 2019 Oct. 5).
  8. ↵
    1. O’Leary R,
    2. MacDonald M,
    3. Stockwell T,
    4. et al
    . Clearing the air: a systematic review on the harms and benefits of e-cigarettes and vapour devices. Victoria (BC): University of Victoria Centre for Addictions Research for BC; 2017.
  9. ↵
    1. El Dib R,
    2. Suzumura EA,
    3. Akl EA
    . Electronic nicotine delivery systems and/or electronic nonnicotine delivery systems for tobacco or reduction: a systematic review and meta-analysis. BMJ Open 2017;7:e012680.
    OpenUrlAbstract/FREE Full Text
  10. ↵
    National Academies of Sciences, Engineering and Medicine. Public health consequences of e-cigarettes. Washington (DC): The National Academies Press; 2018.
  11. ↵
    Centers for Disease Control and Prevention. Nine health threats that made headlines in 2019: a CDC review. Centers for Disease Control and Prevention; 2019. Available: www.cdc.gov/media/releases/2019/p1218-nine-health-threats-2019-review.html (accessed 2019 Dec. 22).
  12. ↵
    1. Soneji SS,
    2. Sung HY,
    3. Primack BA,
    4. et al
    . Quantifying population-level health benefits and harms of e-cigarette use in the United States. PLoS One 2018;13:e0193328.
    OpenUrlCrossRefPubMed
  13. ↵
    1. Wakefield J
    . Instagram e-cigarette posts banned by ad watchdog. Available: www.bbc.com/news/technology-50821476 (accessed 2019 Dec. 22).
PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 192 (3)
CMAJ
Vol. 192, Issue 3
20 Jan 2020
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Evidence-based tobacco-control legislation on e-cigarettes is urgently needed
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Evidence-based tobacco-control legislation on e-cigarettes is urgently needed
Nilanga Aki Bandara, Senara Wanniarachchi, Vahid Mehrnoush
CMAJ Jan 2020, 192 (3) E74; DOI: 10.1503/cmaj.73819

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Evidence-based tobacco-control legislation on e-cigarettes is urgently needed
Nilanga Aki Bandara, Senara Wanniarachchi, Vahid Mehrnoush
CMAJ Jan 2020, 192 (3) E74; DOI: 10.1503/cmaj.73819
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Footnotes
    • References
  • Responses
  • Metrics
  • PDF

Related Articles

  • Parliament debates junk food ads, vaping
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Virtual care and emergency department use
  • The denial of racism is racism itself
  • An expanded role for blood donor emerging pathogens surveillance
Show more Letters

Similar Articles

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • CPD credits
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
  • Accessibiity
  • CMA Civility Standards
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: cmajgroup@cmaj.ca

Powered by HighWire